Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 19,44119,460 of 20,252 grants

Completed TRAINING, INDIVIDUAL
Elucidating the Role of Binding Kinetics in the Development of Abl Kinase Drug Resistance
NATIONAL CANCER INSTITUTE State University New York Stony Brook United States 2021 – 2025

PROJECT SUMMARY The development of small molecule inhibitors has revolutionized targeted therapeutics, especially in the field of protein kinases. However, pharmaceutical developme...

$526.9K
USD
Completed NON-SBIR/STTR RPGS
Genetic code expansion to enable the development of short, diverse peptide libraries
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2021 – 2023

Project Summary Many intracellular cancer targets involve protein-protein interactions that are “undruggable” because the binding surfaces are too large and featureless to be block...

$748.6K
USD
Completed NON-SBIR/STTR RPGS
Leveraging Vulnerabilities Induced by STING Activation in Pancreatic Cancer
NATIONAL CANCER INSTITUTE University of California Los Angeles United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Stimulator of interferon genes (STING) is an emerging target for the treatment of solid tumors. Investigations of the therapeutic relevance of STING agonis...

$968.6K
USD
Completed NON-SBIR/STTR RPGS
Leveraging Vulnerabilities Induced by STING Activation in Pancreatic Cancer
NATIONAL CANCER INSTITUTE University of California Los Angeles United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Stimulator of interferon genes (STING) is an emerging target for the treatment of solid tumors. Investigations of the therapeutic relevance of STING agonis...

$481.5K
USD
Completed NON-SBIR/STTR RPGS
Chemoprevention of lung cancer with the β-blocker carvedilol
NATIONAL CANCER INSTITUTE Western University of Health Sciences United States 2021 – 2023

Abstract Lung cancer is the leading cause of cancer-related death for both men and women.Chronic exposure to carcinogens that are present in tobacco smoking or air pollution is a k...

$705K
USD
Completed OTHER RESEARCH-RELATED
Integrating epidemiologic, clinical, genomic and metabolomic profiles to predict pancreatic cancer risk in a multiethnic population
NATIONAL CANCER INSTITUTE University of Southern California United States 2021 – 2023

ABSTRACT Pancreatic cancer is a highly lethal malignancy that has a very poor prognosis in the United States. It has a 5- year survival rate of only 9% and is projected to become t...

$1.2M
USD
Completed NON-SBIR/STTR RPGS
Leukemia stem cell regulation and resistance
NATIONAL CANCER INSTITUTE University of Alabama At Birmingham United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Chronic myelogenous leukemia (CML) results from hematopoietic stem cell (HSC) transformation by the BCR- ABL tyrosine kinase.Tyrosine kinase inhibitors (TK...

$4.37M
USD
Completed NON-SBIR/STTR RPGS
Neutral sphingomyelinase-2 as a mediator of Doxorubicin-induced cardiotoxicity
NATIONAL CANCER INSTITUTE State University New York Stony Brook United States 2021 – 2026

ABSTRACT Doxorubicin (Dox) is a mainstay in the treatment of many cancers yet its utility is limited by cardiovascular toxicity.While multiple mechanisms underlying this cardiotoxi...

$3.62M
USD
Completed NON-SBIR/STTR RPGS
Modulation of asparagine bioavailability and stress response signaling to enhance T cell robustness and maximize immunotherapy
NATIONAL CANCER INSTITUTE Research Inst Nationwide Children'S Hosp United States 2021 – 2026

Summary: The exquisite specificity, amplitude, and quality of T cells govern tumor initiation, progression, and responses to therapy.Two of the most revolutionary and promising imm...

$5.07M
USD
Completed NON-SBIR/STTR RPGS
Chemoprevention of lung cancer with the β-blocker carvedilol
NATIONAL CANCER INSTITUTE Western University of Health Sciences United States 2021 – 2024

Abstract Lung cancer is the leading cause of cancer-related death for both men and women. Chronic exposure to carcinogens that are present in tobacco smoking or air pollution is a...

$705K
USD
Completed NON-SBIR/STTR RPGS
Neutral sphingomyelinase-2 as a mediator of Doxorubicin-induced cardiotoxicity
NATIONAL CANCER INSTITUTE State University New York Stony Brook United States 2021 – 2026

ABSTRACT Doxorubicin (Dox) is a mainstay in the treatment of many cancers yet its utility is limited by cardiovascular toxicity. While multiple mechanisms underlying this cardiotox...

$3.55M
USD
Completed NON-SBIR/STTR RPGS
Leveraging Vulnerabilities Induced by STING Activation in Pancreatic Cancer
NATIONAL CANCER INSTITUTE University of California Los Angeles United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Stimulator of interferon genes (STING) is an emerging target for the treatment of solid tumors. Investigations of the therapeutic relevance of STING agonis...

$6.03M
USD
Completed NON-SBIR/STTR RPGS
Leukemia stem cell regulation and resistance
NATIONAL CANCER INSTITUTE University of Alabama At Birmingham United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Chronic myelogenous leukemia (CML) results from hematopoietic stem cell (HSC) transformation by the BCR- ABL tyrosine kinase. Tyrosine kinase inhibitors (T...

$4.17M
USD
Completed NON-SBIR/STTR RPGS
Modulation of asparagine bioavailability and stress response signaling to enhance T cell robustness and maximize immunotherapy
NATIONAL CANCER INSTITUTE Research Inst Nationwide Children'S Hosp United States 2021 – 2026

Summary: The exquisite specificity, amplitude, and quality of T cells govern tumor initiation, progression, and responses to therapy.Two of the most revolutionary and promising imm...

$4.7M
USD
Completed OTHER RESEARCH-RELATED
Integrating epidemiologic, clinical, genomic and metabolomic profiles to predict pancreatic cancer risk in a multiethnic population
NATIONAL CANCER INSTITUTE University of Southern California United States 2021 – 2022

ABSTRACT Pancreatic cancer is a highly lethal malignancy that has a very poor prognosis in the United States. It has a 5- year survival rate of only 9% and is projected to become t...

$1.2M
USD
Completed NON-SBIR/STTR RPGS
Biopsy Tract Sealing Device with Magnetic Resonance and X-Ray Image Contrast
NATIONAL CANCER INSTITUTE Texas Engineering Experiment Station United States 2021 – 2026

PROJECT SUMMARY When cancer is suspected in a patient, the tissue in question must be removed and analyzed. This procedure is called a biopsy and is a crucial step in early detecti...

$5.75M
USD
Completed NON-SBIR/STTR RPGS
Leukemia stem cell regulation and resistance
NATIONAL CANCER INSTITUTE University of Alabama At Birmingham United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Chronic myelogenous leukemia (CML) results from hematopoietic stem cell (HSC) transformation by the BCR- ABL tyrosine kinase. Tyrosine kinase inhibitors (T...

$4.04M
USD
Completed NON-SBIR/STTR RPGS
Neutral sphingomyelinase-2 as a mediator of Doxorubicin-induced cardiotoxicity
NATIONAL CANCER INSTITUTE State University New York Stony Brook United States 2021 – 2026

ABSTRACT Doxorubicin (Dox) is a mainstay in the treatment of many cancers yet its utility is limited by cardiovascular toxicity. While multiple mechanisms underlying this cardiotox...

$3.44M
USD
Completed NON-SBIR/STTR RPGS
Modulation of asparagine bioavailability and stress response signaling to enhance T cell robustness and maximize immunotherapy
NATIONAL CANCER INSTITUTE Research Inst Nationwide Children'S Hosp United States 2021 – 2026

Summary: The exquisite specificity, amplitude, and quality of T cells govern tumor initiation, progression, and responses to therapy.Two of the most revolutionary and promising imm...

$4.56M
USD
Completed NON-SBIR/STTR RPGS
Leveraging Vulnerabilities Induced by STING Activation in Pancreatic Cancer
NATIONAL CANCER INSTITUTE University of California Los Angeles United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Stimulator of interferon genes (STING) is an emerging target for the treatment of solid tumors. Investigations of the therapeutic relevance of STING agonis...

$5.76M
USD